Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Gritstone bio Inc GRTSQ

Healthcare Biotechnology
Gritstone bio, Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers next generation cancer and infectious disease immunotherapy candidates. It has developed two vectors that it deploys with the aim of eliciting the desired immune response: self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd). Its two oncology programs in clinical-stage... see more

Recent & Breaking News (PINL:GRTSQ)

Class Action Filed Against Gritstone bio, Inc. (GRTS) - August 6, 2024 Deadline to Join - Contact Levi & Korsinsky

Accesswire June 14, 2024

GRTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Gritstone bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire June 14, 2024

Gritstone bio, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - GRTS

Accesswire June 14, 2024

Lifshitz Law PLLC Announces Investigations of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX), Driven Brands Holdings Inc. (NASDAQ:DRVN), Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), and Gristone bio, Inc. (NASDAQ:GRTS)

Accesswire June 14, 2024

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GRTS

Newsfile June 13, 2024

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Gritstone bio, Inc. (GRTS) Investors

Business Wire June 13, 2024

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Gritstone bio, Inc. (GRTS) on Behalf of Investors

Business Wire June 13, 2024

Shareholders Who Lost Money on Gritstone bio, Inc.(GRTS) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Accesswire June 13, 2024

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire June 13, 2024

Gritstone bio, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before August 6, 2024 to Discuss Your Rights - GRTS

Accesswire June 13, 2024

GRTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Gritstone bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire June 13, 2024

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Gritstone bio, Inc. (GRTS) on Behalf of Investors

Business Wire June 12, 2024

Investors in Gritstone bio, Inc. Should Contact Levi & Korsinsky Before August 6, 2024 to Discuss Your Rights - GRTS

Accesswire June 12, 2024

ROSEN, LEADING INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GRTS

Newsfile June 12, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Gritstone

Newsfile June 12, 2024

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 6, 2024 in Gritstone Lawsuit - GRTS

Accesswire June 12, 2024

GRTS LAWSUIT ALERT: Levi & Korsinsky Notifies Gritstone bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Accesswire June 12, 2024

GRITSTONE BIO, INC. (NASDAQ: GRTS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Gritstone bio, Inc. Investors of Upcoming Deadline

Accesswire June 12, 2024

Levi & Korsinsky Notifies Gritstone bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - GRTS

Accesswire June 12, 2024

GRTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Gritstone bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire June 12, 2024